Approval · Notice of Compliance 9967 · 2008
ALREX: Notice of Compliance 9967
Issued December 23, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9967
- Date
- December 23, 2008
- Company
- Bausch & Lomb Inc.Rochester, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALREX | 02320924 | Marketed |
Medicinal ingredients
- LOTEPREDNOL ETABONATE 0.2 PER